Dow Up0.64% Nasdaq Up0.68%

Achillion Pharmaceuticals, Inc. (ACHN)

-NasdaqGS
11.95 0.00(0.00%) 4:00PM EDT
|After Hours : 11.95 0.00 (0.00%) 4:26PM EDT - Nasdaq Real Time Price
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue -   2,607   247  
Cost of Revenue -   -   -  
Gross Profit -   2,607   247  
Operating Expenses
Research Development46,736  38,999  35,441  
Selling General and Administrative12,741  10,901  9,153  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (59,477) (47,293) (44,347)
Income from Continuing Operations
Total Other Income/Expenses Net582  234  186  
Earnings Before Interest And Taxes(58,895)(47,059)(44,161)
Interest Expense52  68  45  
Income Before Tax(58,947)(47,127)(44,206)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(58,947)(47,127)(44,206)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (58,947) (47,127) (44,206)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (58,947) (47,127) (44,206)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.